Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity
Authors
Keywords
-
Journal
NATURE IMMUNOLOGY
Volume 22, Issue 6, Pages 746-756
Publisher
Springer Science and Business Media LLC
Online
2021-05-25
DOI
10.1038/s41590-021-00940-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion
- (2021) Nicole E. Scharping et al. NATURE IMMUNOLOGY
- The tumor microenvironment as a metabolic barrier to effector T cells and immunotherapy
- (2020) Aaron R Lim et al. eLife
- Sirt2 Inhibition Enhances Metabolic Fitness and Effector Functions of Tumor-Reactive T Cells
- (2020) Imene Hamaidi et al. Cell Metabolism
- Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen
- (2020) Santosha A. Vardhana et al. NATURE IMMUNOLOGY
- Disturbed mitochondrial dynamics in CD8+ TILs reinforce T cell exhaustion
- (2020) Yi-Ru Yu et al. NATURE IMMUNOLOGY
- Checkpoint Blockade Immunotherapy Induces Dynamic Changes in PD-1−CD8+ Tumor-Infiltrating T Cells
- (2019) Sema Kurtulus et al. IMMUNITY
- Intratumoral Tcf1+PD-1+CD8+ T Cells with Stem-like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy
- (2019) Imran Siddiqui et al. IMMUNITY
- Uncoupling protein 2 reprograms the tumor microenvironment to support the anti-tumor immune cycle
- (2019) Wan-Chen Cheng et al. NATURE IMMUNOLOGY
- Loss of MPC1 reprograms retinal metabolism to impair visual function
- (2019) Allison Grenell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Navigating metabolic pathways to enhance antitumour immunity and immunotherapy
- (2019) Xiaoyun Li et al. Nature Reviews Clinical Oncology
- Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade
- (2019) Brian C. Miller et al. NATURE IMMUNOLOGY
- NR4A transcription factors limit CAR T cell function in solid tumours
- (2019) Joyce Chen et al. NATURE
- Clonal Deletion of Tumor-Specific T Cells by Interferon-γ Confers Therapeutic Resistance to Combination Immune Checkpoint Blockade
- (2019) Chien-Chun Steven Pai et al. IMMUNITY
- CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer
- (2019) Laura M. McLane et al. Annual Review of Immunology
- Targeting Tumors with IL-10 Prevents Dendritic Cell-Mediated CD8+ T Cell Apoptosis
- (2019) Jian Qiao et al. CANCER CELL
- TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection
- (2019) Francesca Alfei et al. NATURE
- Pegilodecakin combined with pembrolizumab or nivolumab for patients with advanced solid tumours (IVY): a multicentre, multicohort, open-label, phase 1b trial
- (2019) Aung Naing et al. LANCET ONCOLOGY
- PTPN2 regulates the generation of exhausted CD8+ T cell subpopulations and restrains tumor immunity
- (2019) Martin W. LaFleur et al. NATURE IMMUNOLOGY
- T Cell Dysfunction in Cancer
- (2018) Daniela S. Thommen et al. CANCER CELL
- Adenovirus Coding for Interleukin-2 and Tumor Necrosis Factor Alpha Replaces Lymphodepleting Chemotherapy in Adoptive T Cell Therapy
- (2018) João Manuel Santos et al. MOLECULAR THERAPY
- CAR T cell immunotherapy for human cancer
- (2018) Carl H. June et al. SCIENCE
- Metabolic Control of CD8 + T Cell Fate Decisions and Antitumor Immunity
- (2018) Lianjun Zhang et al. TRENDS IN MOLECULAR MEDICINE
- CART cells are prone to Fas- and DR5-mediated cell death
- (2018) Benjamin O. Tschumi et al. Journal for ImmunoTherapy of Cancer
- PEGylated IL-10 (Pegilodecakin) Induces Systemic Immune Activation, CD8+ T Cell Invigoration and Polyclonal T Cell Expansion in Cancer Patients
- (2018) Aung Naing et al. CANCER CELL
- Metabolic reprogramming of natural killer cells in obesity limits antitumor responses
- (2018) Xavier Michelet et al. NATURE IMMUNOLOGY
- Elements of cancer immunity and the cancer–immune set point
- (2017) Daniel S. Chen et al. NATURE
- Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages
- (2017) W. K. Eddie Ip et al. SCIENCE
- Mitochondrial Dynamics Controls T Cell Fate through Metabolic Programming
- (2016) Michael D. Buck et al. CELL
- Bioenergetic Insufficiencies Due to Metabolic Alterations Regulated by the Inhibitory Receptor PD-1 Are an Early Driver of CD8 + T Cell Exhaustion
- (2016) Bertram Bengsch et al. IMMUNITY
- Follicular CXCR5-expressing CD8+ T cells curtail chronic viral infection
- (2016) Ran He et al. NATURE
- Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy
- (2016) Se Jin Im et al. NATURE
- Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
- (2016) John G Doench et al. NATURE BIOTECHNOLOGY
- Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses
- (2016) Kelly D Moynihan et al. NATURE MEDICINE
- Embryonic Lethality of Mitochondrial Pyruvate Carrier 1 Deficient Mouse Can Be Rescued by a Ketogenic Diet
- (2016) Benoît Vanderperre et al. PLoS Genetics
- Hepatic Mitochondrial Pyruvate Carrier 1 Is Required for Efficient Regulation of Gluconeogenesis and Whole-Body Glucose Homeostasis
- (2015) Lawrence R. Gray et al. Cell Metabolism
- Pembrolizumab versus Ipilimumab in Advanced Melanoma
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anticancer Cytokines: Biology and Clinical Effects of Interferon-α2, Interleukin (IL)-2, IL-15, IL-21, and IL-12
- (2015) Theofanis Floros et al. SEMINARS IN ONCOLOGY
- CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling
- (2014) Randall J. Platt et al. CELL
- Full-length RNA-seq from single cells using Smart-seq2
- (2014) Simone Picelli et al. Nature Protocols
- Immune Modulation in Cancer with Antibodies
- (2013) David B. Page et al. Annual Review of Medicine
- Immunogenicity of Murine Solid Tumor Models as a Defining Feature of In Vivo Behavior and Response to Immunotherapy
- (2013) Melissa G. Lechner et al. JOURNAL OF IMMUNOTHERAPY
- Purification and characterization of human IL-10/Fc fusion protein expressed in Pichia pastoris
- (2012) Yugang Guo et al. PROTEIN EXPRESSION AND PURIFICATION
- Identification and Functional Expression of the Mitochondrial Pyruvate Carrier
- (2012) S. Herzig et al. SCIENCE
- Progenitor and Terminal Subsets of CD8+ T Cells Cooperate to Contain Chronic Viral Infection
- (2012) M. A. Paley et al. SCIENCE
- IL-10 Elicits IFNγ-Dependent Tumor Immune Surveillance
- (2011) John B. Mumm et al. CANCER CELL
- Interleukin-10 Ablation Promotes Tumor Development, Growth, and Metastasis
- (2011) T. Tanikawa et al. CANCER RESEARCH
- Function of Mitochondrial Stat3 in Cellular Respiration
- (2009) J. Wegrzyn et al. SCIENCE
- High‐dose interleukin‐2 for the treatment of metastatic renal cell carcinoma
- (2008) Jacob A. Klapper et al. CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started